Avoid common mistakes on your manuscript.
Correction: Rheumatol Ther (2023) 10:117–133 https://doi.org/10.1007/s40744-022-00491-4
The original article was published with the incorrect keywords “Auto-injector; IL-6, IL-6Ra; Patient preference; Pen, Prefilled syringe; Rheumatoid arthritis; Sarilumab”; the correct keywords are “Rheumatoid arthritis; Psoriatic arthritis; Radiographic progression; Etanercept; Noninterventional study”.
The original article is also updated with the correct keywords.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Wassenberg, S., Rau, R., Klopsch, T. et al. Correction: Etanercept is Effective and Halts Radiographic Progression in Rheumatoid Arthritis and Psoriatic Arthritis: Final Results from a German Non-interventional Study (PRERA). Rheumatol Ther 11, 213 (2024). https://doi.org/10.1007/s40744-023-00579-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40744-023-00579-5